Cargando…

Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration

BACKGROUND: The native articular cartilage lacks the ability to heal. Currently, ex vivo expanded chondrocytes or bone marrow-derived mesenchymal stem cells are used to regenerate the damaged cartilage. With unlimited self-renewal ability and multipotency, human induced pluripotent stem cells (hiPSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Yoojun, Rim, Yeri Alice, Jung, Seung Min, Ju, Ji Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273802/
https://www.ncbi.nlm.nih.gov/pubmed/28129782
http://dx.doi.org/10.1186/s13287-017-0477-6
_version_ 1782501784541986816
author Nam, Yoojun
Rim, Yeri Alice
Jung, Seung Min
Ju, Ji Hyeon
author_facet Nam, Yoojun
Rim, Yeri Alice
Jung, Seung Min
Ju, Ji Hyeon
author_sort Nam, Yoojun
collection PubMed
description BACKGROUND: The native articular cartilage lacks the ability to heal. Currently, ex vivo expanded chondrocytes or bone marrow-derived mesenchymal stem cells are used to regenerate the damaged cartilage. With unlimited self-renewal ability and multipotency, human induced pluripotent stem cells (hiPSCs) have been highlighted as a new replacement cell source for cartilage repair. Still, further research is needed on cartilage regeneration using cord blood mononuclear cell-derived hiPSCs (CBMC-hiPSCs). METHODS: Human iPSCs were generated from CBMCs using the Sendai virus. The characterization of CBMC-hiPSCs was performed by various assays. Embryonic bodies (EBs) were obtained using CBMC-hiPSCs, and outgrowth cells were induced by plating the EBs onto a gelatin-coated plate. Expanded outgrowth cells were detached and dissociated for chondrogenic differentiation. Outgrowth cells were differentiated into chondrogenic lineage with pellet culture. Chondrogenic pellets were maintained for 30 days. The quality of chondrogenic pellets was evaluated using various staining and genetic analysis of cartilage-specific markers. RESULTS: Reprogramming was successfully done using CBMCs. CBMC-hiPSCs (n = 3) showed high pluripotency and normal karyotype. Chondrogenic pellets were generated from the outgrowth cells derived from CBMC-hiPSC EBs. The generated chondrogenic pellets showed high expression of chondrogenic genetic markers such as ACAN, COMP, COL2A1, and SOX9. The production of extracellular matrix (ECM) proteins was confirmed by safranin O, alcian blue and toluidine blue staining. Expression of collagen type II and aggrecan was detected in the accumulated ECM by immunohistological staining. Chondrogenic pellets showed low expression of fibrotic and hypertrophic cartilage marker, collagen type I and X. CONCLUSIONS: This study reveals the potential of CBMC-hiPSCs as a promising candidate for cartilage regeneration. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-017-0477-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5273802
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52738022017-02-01 Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration Nam, Yoojun Rim, Yeri Alice Jung, Seung Min Ju, Ji Hyeon Stem Cell Res Ther Research BACKGROUND: The native articular cartilage lacks the ability to heal. Currently, ex vivo expanded chondrocytes or bone marrow-derived mesenchymal stem cells are used to regenerate the damaged cartilage. With unlimited self-renewal ability and multipotency, human induced pluripotent stem cells (hiPSCs) have been highlighted as a new replacement cell source for cartilage repair. Still, further research is needed on cartilage regeneration using cord blood mononuclear cell-derived hiPSCs (CBMC-hiPSCs). METHODS: Human iPSCs were generated from CBMCs using the Sendai virus. The characterization of CBMC-hiPSCs was performed by various assays. Embryonic bodies (EBs) were obtained using CBMC-hiPSCs, and outgrowth cells were induced by plating the EBs onto a gelatin-coated plate. Expanded outgrowth cells were detached and dissociated for chondrogenic differentiation. Outgrowth cells were differentiated into chondrogenic lineage with pellet culture. Chondrogenic pellets were maintained for 30 days. The quality of chondrogenic pellets was evaluated using various staining and genetic analysis of cartilage-specific markers. RESULTS: Reprogramming was successfully done using CBMCs. CBMC-hiPSCs (n = 3) showed high pluripotency and normal karyotype. Chondrogenic pellets were generated from the outgrowth cells derived from CBMC-hiPSC EBs. The generated chondrogenic pellets showed high expression of chondrogenic genetic markers such as ACAN, COMP, COL2A1, and SOX9. The production of extracellular matrix (ECM) proteins was confirmed by safranin O, alcian blue and toluidine blue staining. Expression of collagen type II and aggrecan was detected in the accumulated ECM by immunohistological staining. Chondrogenic pellets showed low expression of fibrotic and hypertrophic cartilage marker, collagen type I and X. CONCLUSIONS: This study reveals the potential of CBMC-hiPSCs as a promising candidate for cartilage regeneration. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-017-0477-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-28 /pmc/articles/PMC5273802/ /pubmed/28129782 http://dx.doi.org/10.1186/s13287-017-0477-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nam, Yoojun
Rim, Yeri Alice
Jung, Seung Min
Ju, Ji Hyeon
Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
title Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
title_full Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
title_fullStr Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
title_full_unstemmed Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
title_short Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
title_sort cord blood cell-derived ipscs as a new candidate for chondrogenic differentiation and cartilage regeneration
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273802/
https://www.ncbi.nlm.nih.gov/pubmed/28129782
http://dx.doi.org/10.1186/s13287-017-0477-6
work_keys_str_mv AT namyoojun cordbloodcellderivedipscsasanewcandidateforchondrogenicdifferentiationandcartilageregeneration
AT rimyerialice cordbloodcellderivedipscsasanewcandidateforchondrogenicdifferentiationandcartilageregeneration
AT jungseungmin cordbloodcellderivedipscsasanewcandidateforchondrogenicdifferentiationandcartilageregeneration
AT jujihyeon cordbloodcellderivedipscsasanewcandidateforchondrogenicdifferentiationandcartilageregeneration